Discovery, structure-guided design, and validation of WEHI-539, a novel, potent, and selective inhibitor of the pro-survival BCL-2 family member BCL-XL

被引：0

作者：

Lessene, Guillaume ^{[1
,2
]}

Czabotar, Peter E. ^{[1
,2
]}

Sleebs, Brad E. ^{[1
,2
]}

Zobel, Kerry ^{[3
]}

Lowes, Kym L. ^{[1
,2
]}

Adams, Jerry M. ^{[1
,2
]}

Baell, Jonathan B. ^{[1
,2
]}

Colman, Peter M. ^{[1
,2
]}

Deshayes, Kurt ^{[3
]}

Fairbrother, Wayne J. ^{[3
]}

Flygare, John A. ^{[3
]}

Gibbons, Paul ^{[3
]}

Kersten, Wilhelmus J. A. ^{[1
,2
]}

Kulasegaram, Sanji ^{[1
,2
]}

Moss, Rebecca M. ^{[1
,2
]}

Parisot, John P. ^{[1
,2
]}

Smith, Brian J. ^{[1
,2
]}

Street, Ian P. ^{[1
,2
]}

Yang, Hong ^{[1
,2
]}

Huang, David C. S. ^{[1
,2
]}

Watson, Keith G. ^{[1
,2
]}

机构：

[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia

[2] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia

[3] Genentech Inc, Redwood City, CA USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 245卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

310-MEDI

引用

页数：1

共 29 条

[21] The pro-survival Bcl-2 family member A1 delays spontaneous and FAS ligand-induced apoptosis of activated neutrophils
Schenk, Robyn L.
Gangoda, Lahiru
Lawlor, Kate E.
O'Reilly, Lorraine A.
Strasser, Andreas
Herold, Marco J.
CELL DEATH & DISEASE, 2020, 11 (06)
[22] Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment
Schenk, Robyn L.
Tuzlak, Selma
Carrington, Emma M.
Zhan, Yifan
Heinzel, Susanne
Teh, Charis E.
Gray, Daniel H.
Tai, Lin
Lew, Andrew M.
Villunger, Andreas
Strasser, Andreas
Herold, Marco J.
CELL DEATH AND DIFFERENTIATION, 2017, 24 (03): : 534 - 545
[23] GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma
Cournoyer, Sonia
Addioui, Anissa
Belounis, Assila
Beaunoyer, Mona
Nyalendo, Carine
Le Gall, Roxane
Teira, Pierre
Haddad, Elie
Vassal, Gilles
Sartelet, Herve
BMC CANCER, 2019, 19 (01)
[24] Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment
Robyn L Schenk
Selma Tuzlak
Emma M Carrington
Yifan Zhan
Susanne Heinzel
Charis E Teh
Daniel H Gray
Lin Tai
Andrew M Lew
Andreas Villunger
Andreas Strasser
Marco J Herold
Cell Death & Differentiation, 2017, 24 : 534 - 545
[25] GX15–070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma
Sonia Cournoyer
Anissa Addioui
Assila Belounis
Mona Beaunoyer
Carine Nyalendo
Roxane Le Gall
Pierre Teira
Elie Haddad
Gilles Vassal
Hervé Sartelet
BMC Cancer, 19
[26] Expression of Bcl-2 Pro-Survival Family Proteins Predicts Pharmacological Responses to ABT-199, a Novel and Selective Bc1-2 Antagonist, in Multiple Myeloma Models
Sampath, Deepak
Punnoose, Elizabeth
Boghaert, Erwin R.
Belmont, Lisa
Chen, Jun
Peale, Franklin
Nguyen Tan
Darbonne, Walter
Yue, Peng
Oeh, Jason
Lee, Leslie
Fairbrother, Wayne J.
Souers, Andrew J.
Elmore, Steve W.
Leverson, Joel D.
BLOOD, 2012, 120 (21)
[27] MCL-1 Inhibitor-Induced Killing of Multiple Myeloma Is Modulated By the Relative Level of Expression of Pro-Survival Members of the BCL-2 Family and the Proto-Oncogene MYC
Spencer, Andrew
Khong, Tiffany
Chenn, Maoshan
BLOOD, 2019, 134
[28] A Step Forward toward Selective Activation/Inhibition of Bak, a Pro-Apoptotic Member of the Bcl-2 Protein Family: Discovery of New Prospective Allosteric Sites Using Molecular Dynamics
Vila-Julia, Guillem
Perez, Juan J.
Rubio-Martinez, Jaime
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (11) : 3544 - 3556
[29] Use of structure-based design in the discovery of the BCL-2 selective inhibitor Venclexta® and the bromodomain and extra-terminal domain (BET) inhibitors mivebresib and ABBV-744
Hasvold, Lisa
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258

← 1 2 3 →